Google
×
... Email. Leave this field blank. Contact IR. Thomas Dalton Head of Investor & Public Relations (913) 942-2301. IR@cingulate.com. CTx®_4C. TwitterLinkedIn ...
News Releases. Investor Menu ... Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update ... Feb 28, 2024. Compass Therapeutics Announces ...
CTX-009 Phase 2 Results in BTC Presented at ASCO GI Presentation 1.1 MB. Live Teleconference Information. Investors Dial: 1-877-704-4453. Int'l Investors Dial ...
View the largest selection of Direct Stock Purchase Plans in the Industry? Invest Now. Need help? Our virtual agent is available 24/7 ...
Missing: ctx | Show results with:ctx
Presentations. Cingulate March 2024 Investor Presentation 3.1 MB. LD Micro Main Event XVI Presentation · CTx-1301 Psych Congress Presentation 2023 846.1 KB ...
Presentations. Investor Presentation - November 2023. Crescita Therapeutics Inc. (TSX:CTX) opened Toronto Stock Exchange on April 26, 2016. crescita-768x512.
Mar 22, 2011 · (Pink Sheets: CTXV) announced today that it has engaged Wall Street Edge Investor Relations (WSE) to provide investor relations and financial ...
People also ask
Captor Therapeutics is a high-tech pharmaceutical company focused on targeting the undruggable proteome.
Crescita Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CTX.CA financial statements in full.
Missing: relations | Show results with:relations
CTX is an emerging asset management firm headquartered in Texas. We make targeted investments in early-stage companies that offer the best opportunities for ...